Back to top
more

Intuitive Surgical (ISRG)

(Real Time Quote from BATS)

$507.46 USD

507.46
189,566

+1.12 (0.22%)

Updated Nov 4, 2024 11:50 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Boston Scientific (BSX) Set to Acquire Relievant Medsystems

by Zacks Equity Research

Boston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio.

Align (ALGN) Gains From Growing Invisalign Volume, Innovation

by Zacks Equity Research

Align Technology (ALGN) is expanding its sales and marketing by reaching new countries and regions, including new areas within Africa and Latin America.

Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM

by Zacks Equity Research

Medtronic's (MDT) next-generation sensor Simplera receives CE Mark approval.

John Blank headshot

Did a Data-Driven Fed Get it Right?

by John Blank

The FOMC meeting is done. Let's discuss the latest macro facts.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Investors Should Buy Alcon (ALC) Stock Right Now

by Zacks Equity Research

Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.

Abbott (ABT) to Commercialize Biosimilars in Emerging Markets

by Zacks Equity Research

Abbott (ABT) is set to commercialize several biosimilar molecules in key emerging markets via an expanded collaboration with mAbxience.

Orthofix (OFIX) Unveils Gemini System, Advances in Trauma Wing

by Zacks Equity Research

According to Orthofix (OFIX), with the launch of the Galaxy Fixation Gemini system surgeons now have efficient solutions for lower extremity trauma scenarios where time is an important factor.

3 Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.

Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $299.65, moving +0.5% from the previous trading session.

The Zacks Analyst Blog Highlights Intuitive Surgical, Ingersoll Rand and Weyerhaeuser

by Zacks Equity Research

Intuitive Surgical, Ingersoll Rand and Weyerhaeuser are part of the Zacks top Analyst Blog.

Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $298.17, moving +0.89% from the previous trading session.

John Blank headshot

To Center Stage for the Fed: Global Week Ahead

by John Blank

The Fed is widely expected to leave its key rate at 5.25-5.50%. Latest inflation numbers were slightly stronger than expected, but that has done little to bolster the case for an imminent rate increase.

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Intuitive Surgical, Inc. (ISRG). This makes it worthwhile to examine what the stock has in store.

Philips (PHG) Expands Mobile C-arm Portfolio With Zenition 30

by Zacks Equity Research

Philips (PHG) expands its mobile C-arm lineup with Zenition 30, which provides surgeons with more control and customization.

UnitedHealth Group (UNH) Wins Medicaid Deal to Help Serve Texas

by Zacks Equity Research

UnitedHealth Group (UNH) unit has been awarded a contract by the Texas Health and Human Services Commission to better cater to the statewide Medicaid members.

Strength Seen in Pacific Biosciences (PACB): Can Its 8.9% Jump Turn into More Strength?

by Zacks Equity Research

Pacific Biosciences (PACB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Intuitive Surgical, Inc. (ISRG) Stock Moves -0.24%: What You Should Know

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) closed at $301.62 in the latest trading session, marking a -0.24% move from the prior day.

Are Medical Stocks Lagging Augmedix (AUGX) This Year?

by Zacks Equity Research

Here is how Augmedix, Inc. (AUGX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $307.84, marking a +0.05% move from the previous day.

Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $312.68, moving -1.85% from the previous trading session.

Idexx (IDXX) Down 1.6% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

by Zacks Equity Research

Sector ETF report for RSPH

Intuitive Surgical, Inc. (ISRG) Is Considered a Good Investment by Brokers: Is That True?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), Intuitive Surgical, Inc. (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?